These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6366438)

  • 61. Patients compliance in hypertension--the importance of number of tablets.
    Asplund J; Danielson M; Ohman P
    Br J Clin Pharmacol; 1984 May; 17(5):547-52. PubMed ID: 6375710
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Long-term management of arterial hypertension using a beta-adrenolytic agent in combination with a saluretic].
    Fryda-Kaurimsky Z; Krüger K; Krüger K
    Med Welt; 1979 Apr; 30(15):572-5. PubMed ID: 449649
    [No Abstract]   [Full Text] [Related]  

  • 63. [Pindolol in benign essential hypertension. A group study by 12 Zürich internists].
    Rhomberg F; Bächtold H; Danczkay I; Hugentobler F; Jaccard G; Kälin R; Pugatsch I; Stauffenegger M; Veraguth F; Waldvogel W
    Schweiz Med Wochenschr; 1979 Jun; 109(26):990-4. PubMed ID: 462166
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Glomerular filtrate, renal plasma flow, and sodium excretion in hypertensive patients before and following antihypertensive treatment with combination preparations].
    Habermann W; Stumpe KO; Krück F
    Med Klin; 1972 Oct; 67(42):1363-7. PubMed ID: 4629612
    [No Abstract]   [Full Text] [Related]  

  • 66. [Hypertension therapy with Briserin: what role do dihydroergocristine components play?].
    Schardt F; Polzien P
    Med Klin; 1981 Dec; 76(26):746-52. PubMed ID: 6798382
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Long-term study of the antihypertensive effect of the pindolol and clopamide combination].
    Padovan GC; Gruppillo P; Masoni C; Tomaini MD
    G Ital Cardiol; 1981; 11(10):1456-9. PubMed ID: 7341315
    [No Abstract]   [Full Text] [Related]  

  • 68. [The effect of an antihypertensive drug during psychological stress. A double-blind study].
    Rösler F; Wegener H; Eulenberger D; Dahme B
    Arzneimittelforschung; 1975 Jun; 25(6):965-72. PubMed ID: 809046
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of hypertension in the elderly with pindolol and clopamide.
    Persson I
    J Am Geriatr Soc; 1978 Aug; 26(8):337-40. PubMed ID: 670620
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].
    Werning C; Hammerschmidt D; Kaiser Hj
    Med Welt; 1978 Oct; 29(40):1570-5. PubMed ID: 703579
    [No Abstract]   [Full Text] [Related]  

  • 71. [Ambulatory therapy of hypertension with briserin].
    Jüptner H
    Z Allgemeinmed; 1969 Oct; 45(29):1392-4. PubMed ID: 5386127
    [No Abstract]   [Full Text] [Related]  

  • 72. [Treatment of hypertensive patients with adelphan-esidrex].
    Shvedenko LA; Parashchak AP; Ryzhova VL
    Klin Med (Mosk); 1983 Aug; 61(8):24-8. PubMed ID: 6358666
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 74. Antihypertensive effects of pindolol.
    Gonasun LM
    Am Heart J; 1982 Aug; 104(2 Pt 2):374-87. PubMed ID: 7048877
    [No Abstract]   [Full Text] [Related]  

  • 75. [Treatment of arterial hypertension by pindolol].
    Guédon J; Lucsko M; Chaignon M
    Nouv Presse Med; 1976 Feb; 5(8):511-2. PubMed ID: 817263
    [No Abstract]   [Full Text] [Related]  

  • 76. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 77. A comparative trial of fixed ratio beta-adrenoceptor blocker and diuretic combination products in moderate hypertension.
    Watt SJ; Lee MR
    Pharmatherapeutica; 1980; 2(7):487-93. PubMed ID: 6111083
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of pindolol and clopamide on blood lipids in arterial hypertensive patients.
    Román O; Pino ME; Valenzuela A
    Cardiology; 1987; 74(3):219-25. PubMed ID: 3594511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.